Cargando…
Neurogenic Erectile Dysfunction. Where Do We Stand?
Erectile Dysfunction (ED) is the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance, causing tremendous effects on both patients and their partners. The pathophysiology of ED remains a labyrinth. The underlying mechanisms of ED may be vasculo...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825654/ https://www.ncbi.nlm.nih.gov/pubmed/33430218 http://dx.doi.org/10.3390/medicines8010003 |
_version_ | 1783640357078040576 |
---|---|
author | Thomas, Charalampos Konstantinidis, Charalampos |
author_facet | Thomas, Charalampos Konstantinidis, Charalampos |
author_sort | Thomas, Charalampos |
collection | PubMed |
description | Erectile Dysfunction (ED) is the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance, causing tremendous effects on both patients and their partners. The pathophysiology of ED remains a labyrinth. The underlying mechanisms of ED may be vasculogenic, neurogenic, anatomical, hormonal, drug-induced and/or psychogenic. Neurogenic ED consists of a large cohort of ED, accounting for about 10% to 19% of all cases. Its diversity does not allow an in-depth clarification of all the underlying mechanisms nor a “one size fits all” therapeutical approach. In this review, we focus on neurogenic causes of ED, trying to elucidate the mechanisms that lie beneath it and how we manage these patients. |
format | Online Article Text |
id | pubmed-7825654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78256542021-01-24 Neurogenic Erectile Dysfunction. Where Do We Stand? Thomas, Charalampos Konstantinidis, Charalampos Medicines (Basel) Review Erectile Dysfunction (ED) is the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance, causing tremendous effects on both patients and their partners. The pathophysiology of ED remains a labyrinth. The underlying mechanisms of ED may be vasculogenic, neurogenic, anatomical, hormonal, drug-induced and/or psychogenic. Neurogenic ED consists of a large cohort of ED, accounting for about 10% to 19% of all cases. Its diversity does not allow an in-depth clarification of all the underlying mechanisms nor a “one size fits all” therapeutical approach. In this review, we focus on neurogenic causes of ED, trying to elucidate the mechanisms that lie beneath it and how we manage these patients. MDPI 2021-01-07 /pmc/articles/PMC7825654/ /pubmed/33430218 http://dx.doi.org/10.3390/medicines8010003 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Thomas, Charalampos Konstantinidis, Charalampos Neurogenic Erectile Dysfunction. Where Do We Stand? |
title | Neurogenic Erectile Dysfunction. Where Do We Stand? |
title_full | Neurogenic Erectile Dysfunction. Where Do We Stand? |
title_fullStr | Neurogenic Erectile Dysfunction. Where Do We Stand? |
title_full_unstemmed | Neurogenic Erectile Dysfunction. Where Do We Stand? |
title_short | Neurogenic Erectile Dysfunction. Where Do We Stand? |
title_sort | neurogenic erectile dysfunction. where do we stand? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825654/ https://www.ncbi.nlm.nih.gov/pubmed/33430218 http://dx.doi.org/10.3390/medicines8010003 |
work_keys_str_mv | AT thomascharalampos neurogenicerectiledysfunctionwheredowestand AT konstantinidischaralampos neurogenicerectiledysfunctionwheredowestand |